Arcus Biosciences logo

Arcus Biosciences share price today

(RCUS)

Arcus Biosciences share price is $14.87 & ₹1,275.99 as on 7 Jan 2025, 2.30 'hrs' IST

$14.87

-0.19

(-1.26%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Arcus Biosciences share price in Dollar and Rupees. Guide to invest in Arcus Biosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Arcus Biosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Arcus Biosciences share price movements

  • Today's Low: $14.87
    Today's High: $15.39

    Day's Volatility :3.38%

  • 52 Weeks Low: $13.52
    52 Weeks High: $20.31

    52 Weeks Volatility :33.43%

Arcus Biosciences Returns

PeriodArcus Biosciences IncSector (Health Care)Index (Russel 2000)
3 Months
-13.8%
-8.4%
0.0%
6 Months
6.96%
-3.8%
0.0%
1 Year
-19.81%
-0.1%
0.0%
3 Years
-59.9%
2.9%
-19.8%

Arcus Biosciences Key Statistics

in dollars & INR

Previous Close
$15.06
Open
$15.03
Today's High
$15.39
Today's Low
$14.87
Market Capitalization
$1.4B
Today's Volume
$362.4K
52 Week High
$20.31
52 Week Low
$13.52
Revenue TTM
$263.0M
EBITDA
$-288.0M
Earnings Per Share (EPS)
$-3.19
Profit Margin
-102.66%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-49.77%

How to invest in Arcus Biosciences from India?

It is very easy for Indian residents to invest directly in Arcus Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Arcus Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Arcus Biosciences or RCUS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Arcus Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Arcus Biosciences shares which would translate to 0.058 fractional shares of Arcus Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Arcus Biosciences, in just a few clicks!

Returns in Arcus Biosciences for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Arcus Biosciences investment value today

Current value as on today

₹82,403

Returns

₹17,597

(-17.6%)

Returns from Arcus Biosciences Stock

₹20,820 (-20.82%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Arcus Biosciences

73%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Arcus Biosciences on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 73% more investors are searching Arcus Biosciences in the last 30 days versus the previous period.

Global Institutional Holdings in Arcus Biosciences

  • BlackRock Inc

    10.67%

  • Vanguard Group Inc

    5.98%

  • FMR Inc

    4.88%

  • Woodline Partners LP

    3.80%

  • State Street Corp

    3.29%

  • Point72 Asset Management, L.P.

    2.66%

Analyst Recommendation on Arcus Biosciences

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 18 Wall street analysts offering stock ratings for Arcus Biosciences(by analysts ranked 0 to 5 stars)

Based on 18 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
15
15
14
Hold
3
3
3
Sell
0
0
0

Analyst Forecast on Arcus Biosciences

What analysts predicted

Upside of 123.27%

Current:

$14.87

Target:

$33.20

Insights on Arcus Biosciences

  • Price Movement

    In the last 1 month, RCUS stock has moved down by -12.9%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 39.0M → 48.0M (in $), with an average increase of 18.8% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -93.0M → -92.0M (in $), with an average increase of 1.1% per quarter
  • RCUS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 38.8%
  • RCUS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 116.0%
  • Price to Sales

    ForRCUS every $1 of sales, investors are willing to pay $4.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Arcus Biosciences Financials in INR & Dollars

FY18Y/Y Change
Revenue
$8.4M
↑ 491.15%
Net Income
$-49.6M
↓ 6.57%
Net Profit Margin
-593.73%
↑ 3162.96%
FY19Y/Y Change
Revenue
$15.0M
↑ 79.58%
Net Income
$-75.9M
↑ 53.11%
Net Profit Margin
-506.21%
↑ 87.52%
FY20Y/Y Change
Revenue
$77.5M
↑ 416.78%
Net Income
$-116.7M
↑ 53.66%
Net Profit Margin
-150.52%
↑ 355.69%
FY21Y/Y Change
Revenue
$382.9M
↑ 393.93%
Net Income
$53.0M
↓ 145.42%
Net Profit Margin
13.84%
↑ 164.36%
FY22Y/Y Change
Revenue
$112.0M
↓ 70.75%
Net Income
$-267.0M
↓ 603.77%
Net Profit Margin
-238.39%
↓ 252.23%
FY23Y/Y Change
Revenue
$117.0M
↑ 4.46%
Net Income
$-307.0M
↑ 14.98%
Net Profit Margin
-262.39%
↓ 24.0%
Q2 FY23Q/Q Change
Revenue
$29.0M
↑ 16.0%
Net Income
$-75.0M
↓ 6.25%
Net Profit Margin
-258.62%
↑ 61.38%
Q3 FY23Q/Q Change
Revenue
$32.0M
↑ 10.34%
Net Income
$-71.0M
↓ 5.33%
Net Profit Margin
-221.88%
↑ 36.74%
Q4 FY23Q/Q Change
Revenue
$31.0M
↓ 3.12%
Net Income
$-81.0M
↑ 14.08%
Net Profit Margin
-261.29%
↓ 39.41%
Q1 FY24Q/Q Change
Revenue
$145.0M
↑ 367.74%
Net Income
$-4.0M
↓ 95.06%
Net Profit Margin
-2.76%
↑ 258.53%
Q2 FY24Q/Q Change
Revenue
$39.0M
↓ 73.1%
Net Income
$-93.0M
↑ 2225.0%
Net Profit Margin
-238.46%
↓ 235.7%
Q3 FY24Q/Q Change
Revenue
$48.0M
↑ 23.08%
Net Income
$-92.0M
↓ 1.08%
Net Profit Margin
-191.67%
↑ 46.79%
FY18Y/Y Change
Profit
$8.4M
↑ 491.15%
FY19Y/Y Change
Profit
$15.0M
↑ 79.58%
FY20Y/Y Change
Profit
$-81.5M
↓ 643.22%
FY21Y/Y Change
Profit
$375.8M
↓ 561.23%
FY22Y/Y Change
Profit
$98.0M
↓ 73.92%
FY23Y/Y Change
Profit
$-223.0M
↓ 327.55%
Q2 FY23Q/Q Change
Profit
$25.0M
↑ 19.05%
Q3 FY23Q/Q Change
Profit
$29.0M
↑ 16.0%
Q4 FY23Q/Q Change
Profit
$26.0M
↓ 10.34%
Q1 FY24Q/Q Change
Profit
$142.0M
↑ 446.15%
Q2 FY24Q/Q Change
Profit
$37.0M
↓ 73.94%
Q3 FY24Q/Q Change
Profit
$48.0M
↑ 29.73%
FY18Y/Y Change
Operating Cash Flow
$-43.0M
↑ 71.58%
Investing Cash Flow
$-113.4M
↑ 131.18%
Financing Cash Flow
$129.1M
↑ 20.19%
FY19Y/Y Change
Operating Cash Flow
$-73.5M
↑ 70.86%
Investing Cash Flow
$59.2M
↓ 152.2%
Financing Cash Flow
$1.1M
↓ 99.13%
FY20Y/Y Change
Operating Cash Flow
$111.2M
↓ 251.33%
Investing Cash Flow
$-434.4M
↓ 833.58%
Financing Cash Flow
$438.7M
↑ 38962.78%
FY21Y/Y Change
Operating Cash Flow
$-256.2M
↓ 330.43%
Investing Cash Flow
$-3.9M
↓ 99.11%
Financing Cash Flow
$237.3M
↓ 45.9%
FY22Y/Y Change
Operating Cash Flow
$438.0M
↓ 270.98%
Investing Cash Flow
$-413.0M
↑ 10577.35%
Financing Cash Flow
$33.0M
↓ 86.1%
Q2 FY23Q/Q Change
Operating Cash Flow
$-57.0M
↓ 41.84%
Investing Cash Flow
$26.0M
↓ 79.84%
Financing Cash Flow
$23.0M
↑ 2200.0%
Q3 FY23Q/Q Change
Operating Cash Flow
$-63.0M
↑ 10.53%
Investing Cash Flow
$11.0M
↓ 57.69%
Financing Cash Flow
$6.0M
↓ 73.91%

Arcus Biosciences Technicals Summary

Sell

Neutral

Buy

Arcus Biosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Arcus Biosciences Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Arcus Biosciences Inc
-13.8%
6.96%
-19.81%
-59.9%
47.94%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Arcus Biosciences Inc
14.37
NA
NA
-3.16
-0.5
-0.15
NA
6.18
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Arcus Biosciences Inc
Buy
$1.4B
47.94%
14.37
-102.66%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Arcus Biosciences

arcus biosciences is an exciting young company founded on a vision of creating new cancer therapeutics through the utilization of emerging insights in immunology. arcus was formed in 2015 by a group of seasoned researchers from the biotechnology and pharmaceutical industries and is located in the san francisco bay area, in the heart of the world’s largest biotechnology research hub. unlike many other organizations, we view the drug discovery process as one that requires equal parts of technology and art, science and elegance, not as a commodity that can be outsourced. for this reason, we have assembled and are continuing to build an internal team of uniquely qualified individuals with extraordinary knowledge, skills and drive. arcus is rapidly establishing a portfolio of novel therapeutics encompassing both small molecules and biologics that target various facets of the immune system implicated in pathology or modulation of the cellular processes of cancer. these new drugs will then be
Organization
Arcus Biosciences
Employees
577
CEO
Dr. Terry J. Rosen Ph.D.
Industry
Health Technology

Management People of Arcus Biosciences

NameTitle
Dr. Terry J. Rosen Ph.D.
Co-Founder, Chairman & CEO
Dr. Juan Carlos Jaen Ph.D.
Co- Founder & President
Mr. Robert C. Goeltz II
Principal Financial Officer & CFO
Ms. Jennifer A. Jarrett M.B.A.
Chief Operating Officer
Dr. Dimitry S.A. Nuyten M.D., Ph.D.
Chief Medical Officer
Dr. K. Christopher Garcia Ph.D.
Co-Founder & Member of Scientific Advisory Board
Mr. Alexander Azoy CPA
VP of Finance & Principal Accounting Officer
Dr. Jonathan Yingling Ph.D.
Chief Scientific Officer
Pia Eaves
Vice President of Investor Relations & Strategy
Ms. Carolyn C. Tang J.D.
General Counsel & Corporate Secretary

Important FAQs about investing in Arcus Biosciences from India :

What is Arcus Biosciences share price today?

Arcus Biosciences share price today stands at $14.87, Open: $15.03 ; Previous Close: $15.06 ; High: $15.39 ; Low: $14.87 ; 52 Week High: $20.31 ; 52 Week Low: $13.52. The stock opens at $15.03, after a previous close of $15.06. The stock reached a daily high of $15.39 and a low of $14.87, with a 52-week high of $20.31 and a 52-week low of $13.52.

Can Indians buy Arcus Biosciences shares?

Yes, Indians can invest in the Arcus Biosciences (RCUS) from India.

With INDmoney, you can buy Arcus Biosciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Arcus Biosciences at zero transaction cost.

How can I buy Arcus Biosciences shares from India?

It is very easy to buy Arcus Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Arcus Biosciences be purchased?

Yes, you can buy fractional shares of Arcus Biosciences with INDmoney app.

What are the documents required to start investing in Arcus Biosciences stocks?

To start investing in Arcus Biosciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Arcus Biosciences

Today’s highest price of Arcus Biosciences (RCUS) is $15.39.

Today’s lowest price of Arcus Biosciences (RCUS) is $14.87.

What is today's market capitalisation of Arcus Biosciences

Today's market capitalisation of Arcus Biosciences RCUS is 1.4B

What is the 52 Week High and Low Range of Arcus Biosciences

  • 52 Week High

    $20.31

  • 52 Week Low

    $13.52

What are the historical returns of Arcus Biosciences?

  • 1 Month Returns

    -13.8%

  • 3 Months Returns

    6.96%

  • 1 Year Returns

    -19.81%

  • 5 Years Returns

    47.94%

Who is the Chief Executive Officer (CEO) of Arcus Biosciences

Dr. Terry J. Rosen Ph.D. is the current Chief Executive Officer (CEO) of Arcus Biosciences.